Evolus to Participate in the Barclays Global Healthcare Conference
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company, will participate in the Barclays Global Healthcare Conference on March 14, 2023, from 2:35 to 3:00 PM ET in Miami Beach, Florida. The event will be accessible via an audio webcast on Evolus' investor relations page at www.evolus.com, with a replay available for 90 days post-event. Evolus aims to revolutionize the aesthetic neurotoxin market with its flagship product, Jeuveau®, a neurotoxin solely dedicated to aesthetics, produced using Hi-Pure™ technology. More details can be found on their official website.
- None.
- None.
Event: |
|
|
||
Date: |
|
|
||
Time: |
|
|
An audio webcast of this event will be available on the investor relations section of Evolus’ website at www.evolus.com. A replay of the webcast will be available for 90 days after the date of the presentation.
About
Jeuveau® is a registered trademark of
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228005039/en/
Investor/Media Contact:
Vice President, Investor Relations
Tel: 949-966-1798
Email: david.erickson@evolus.com
Media Contact:
Email: media@evolus.com
Source:
FAQ
What event will Evolus, Inc. participate in on March 14, 2023?
What time will Evolus present at the Barclays Global Healthcare Conference?
Where is the Barclays Global Healthcare Conference held?
How can I access the audio webcast of Evolus' presentation?